Standardized In Vitro Diagnostic Reagent R&D Management

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

In vitro diagnostic reagent products, particularly molecular diagnostic reagents, face challenges in compatibility across different testing equipment, leading to inefficiencies and delays in diagnostic testing, especially in primary and secondary hospitals, due to duplicate research and development efforts and lack of standardized processes.

Innovation Solution

A device and method for managing research and development of in vitro diagnostic reagents that provide a standardized research and development process through a management program, enabling companies to use the same technology, equipment, and raw materials, and share data in a compatible format, facilitating testing on unified equipment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If each research and development company develops reagent products independently with different processes and equipment, then companies can create customized products, but duplicate research and development efforts occur and compatibility across testing equipment is lost

Engineering Contradiction:

Improveproduct customizationVSAvoidduplicate R&D efforts

Core Design Contradiction:

Adaptability or versatilityVSLoss of time

Solution Approach 1:

The patent segments the R&D process into standardized modules that can be independently developed and then integrated. Different companies can work on different modules simultaneously using the same standardized processes, avoiding duplicate efforts while maintaining product customization capabilities through modular assembly.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent establishes universal standardized R&D processes and data formats that can be used by multiple companies across different medical departments. This universality enables compatibility across testing equipment while still allowing companies to develop customized reagent products for specific diseases or patient needs.

Inventive Principle:

Principle #6Universality (Multi-functionality)

2Reliability

If standardized research and development processes are implemented across companies, then compatibility and data sharing improve, but flexibility in developing customized products for specific diseases may be reduced

Engineering Contradiction:

Improvedata compatibilityVSAvoidproduct customization flexibility

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies local quality by allowing standardized processes to govern the core R&D framework while permitting company-specific adaptations in areas such as target antigen selection, disease-specific parameters, and product formulation. This enables data compatibility at the system level while maintaining flexibility for customized product development.

Inventive Principle:

Principle #3Local quality

Solution Approach 2:

The patent creates a dynamic system where standardized processes provide a stable foundation for data compatibility, while companies can dynamically adjust specific development parameters based on disease requirements and market needs. The standardized framework adapts to accommodate various customization scenarios without compromising overall compatibility.

Inventive Principle:

Principle #15Dynamics

3Adaptability or versatility

If multiple types of testing equipment are used by different companies, then diverse reagent products can be developed, but testing efficiency decreases and early-stage diagnostics become less accessible

Engineering Contradiction:

Improvereagent product diversityVSAvoidtesting efficiency

Core Design Contradiction:

Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent establishes universal testing equipment specifications and standardized reagent formats that enable a single type of testing equipment to process diverse reagent products from different companies. This universality maintains product diversity while significantly improving testing efficiency and making early-stage diagnostics more accessible to hospitals.

Inventive Principle:

Principle #6Universality (Multi-functionality)

4Adaptability or versatility

If companies use different raw materials and production processes, then product innovation is encouraged, but production costs increase and price reduction becomes difficult

Engineering Contradiction:

Improveproduct innovationVSAvoidproduction cost

Core Design Contradiction:

Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The patent maintains product innovation by allowing companies to change specific parameters such as antigen targets, disease applications, and performance characteristics while using standardized production processes and compatible raw materials. This approach enables innovation in product functionality while controlling production costs through process standardization and economies of scale.

Inventive Principle:

Principle #35Parameter changes

Data Source

PatentUS20250298941A1Device and method for managing research and development of in vitro diagnostic reagent products

Publication Date: 2025.09.25 SEEGENE INC

AI summary

Proposed are a device and a method for managing research and development of in vitro diagnostic reagent products. The device and the method may provide a development process through a research and development management program provided to research and development companies that develop in vitro diagnostic reagent products. The device and the method may also allow each of the research and development companies to develop reagent products through a development process according to a standardized policy such that all reagent products can be tested using the same in vitro diagnostic device.